Pharmac - Discontinuation: Ketoprofen (Oruvail) SR Capsules 200mg

Discontinuation:

We are writing to inform you that Sanofi is discontinuing supply of ketoprofen (Oruvail) SR Capsules 200mg. 

Key Date:

• It is estimated that Oruvail stock will be depleted by 31 March 2026

Key messages:

• Please arrange for your affected patients to transition to other NSAIDs or treatments.

• For more information, please see Oruvail on Pharmac website

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

Please share this information:

Please share this information with your colleagues and within your networks.

Ngā mihi,

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington